Corcept Therapeutics Incorporated
CORT
$33.26
-$0.05-0.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 99.65M | 106.11M | 133.66M | 133.99M | 141.21M |
| Total Depreciation and Amortization | 1.89M | 1.87M | 1.89M | 1.62M | 1.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.86M | 48.11M | 15.16M | 13.43M | 10.23M |
| Change in Net Operating Assets | -1.41M | 7.51M | 31.72M | 30.63M | 45.53M |
| Cash from Operations | 142.00M | 163.61M | 182.42M | 179.67M | 198.30M |
| Capital Expenditure | -211.00K | -282.00K | -1.92M | -2.28M | -2.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.97M | 17.52M | -39.52M | -169.49M | -175.43M |
| Cash from Investing | 69.76M | 17.24M | -41.44M | -171.76M | -177.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.49M | 22.59M | 20.66M | 11.38M | 9.62M |
| Repurchase of Common Stock | -245.86M | -216.30M | -189.05M | -78.99M | -37.97M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -220.37M | -193.71M | -168.39M | -67.61M | -28.35M |
| Foreign Exchange rate Adjustments | 1.44M | 716.00K | 1.57M | -228.00K | -228.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.17M | -12.15M | -25.84M | -59.93M | -7.89M |